Arrow Capital Management, LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
+21,760
(15.5%)
New positions
4
Sold out positions
5
Turnover %
38.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| WALGREEN CO | 18,984 | NEW |
| Endo International plc | 13,730 | NEW |
| TDG | 3,503 | 72.5% |
| Bausch Health | 2,604 | 12.3% |
| ZULILY INC | 2,008 | NEW |
| LNG | 1,882 | NEW |
| W R GRACE & CO | 1,605 | 27.5% |
| HRB | 842 | 4.0% |
Top Reduces (Value $000, Stocks/ETFs)
| ENDO PHARMACEUTICALS HLDGS | -11,940 | -100.0% |
| CRI | -7,631 | -36.9% |
| LBTYA | -6,653 | -60.9% |
| CHARTER COMMUNICATIO | -4,783 | -52.6% |
| SBGI | -1,787 | -100.0% |
| TRIP | -1,723 | -100.0% |
| MA | -1,556 | -10.6% |
| TESORO CORP | -1,463 | -100.0% |
| NORTHSTAR RLTY FIN CORP | -1,345 | -100.0% |
| MCGRAW HILL COS | -256 | -2.4% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
18,643
(11.5% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|